These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9731645)

  • 1. Verapamil therapy in infants with hypertrophic cardiomyopathy.
    Moran AM; Colan SD
    Cardiol Young; 1998 Jul; 8(3):310-9. PubMed ID: 9731645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function.
    Anderson DM; Raff GL; Ports TA; Brundage BH; Parmley WW; Chatterjee K
    Br Heart J; 1984 May; 51(5):523-9. PubMed ID: 6539120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of verapamil on haemodynamic function and myocardial metabolism in patients with hypertrophic cardiomyopathy.
    Wilmshurst PT; Thompson DS; Juul SM; Jenkins BS; Webb-Peploe MM
    Br Heart J; 1986 Dec; 56(6):544-53. PubMed ID: 3801246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of verapamil in children and adolescents with hypertrophic cardiomyopathy.
    Spicer RL; Rocchini AP; Crowley DC; Vasiliades J; Rosenthal A
    Circulation; 1983 Feb; 67(2):413-20. PubMed ID: 6681534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.
    Rosing DR; Kent KM; Borer JS; Seides SF; Maron BJ; Epstein SE
    Circulation; 1979 Dec; 60(6):1201-7. PubMed ID: 574066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acute and chronic effects of verapamil on left ventricular function in patients with hypertrophic cardiomyopathy.
    Bonow RO; Rosing DR; Epstein SE
    Eur Heart J; 1983 Nov; 4 Suppl F():57-65. PubMed ID: 6686545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy.
    Rosing DR; Idänpään-Heikkilä U; Maron BJ; Bonow RO; Epstein SE
    Am J Cardiol; 1985 Jan; 55(3):185B-195B. PubMed ID: 3881913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: pressure-volume analysis with a nonimaging scintillation probe.
    Bonow RO; Ostrow HG; Rosing DR; Cannon RO; Lipson LC; Maron BJ; Kent KM; Bacharach SL; Green MV
    Circulation; 1983 Nov; 68(5):1062-73. PubMed ID: 6684510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
    Haberer T; Hess OM; Jenni R; Krayenbühl HP
    Z Kardiol; 1983 Sep; 72(9):487-93. PubMed ID: 6415946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hypertrophic cardiomyopathy: relation to pathological mechanisms.
    Kaltenbach M; Hopf R
    J Mol Cell Cardiol; 1985 Jul; 17 Suppl 2():59-68. PubMed ID: 4040978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disopyramide use in infants and children with hypertrophic cardiomyopathy.
    O'Connor MJ; Miller K; Shaddy RE; Lin KY; Hanna BD; Ravishankar C; Rossano JW
    Cardiol Young; 2018 Apr; 28(4):530-535. PubMed ID: 29513203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute intravenous versus chronic oral drug effects of verapamil on left ventricular diastolic function in patients with hypertrophic cardiomyopathy.
    Posma JL; Blanksma PK; Van der Wall E; Lie KI
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):969-73. PubMed ID: 7898081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Echocardiographic and hemodynamic studies on the influence of verapamil in hypertrophic obstructive cardiomyopathy (author's transl)].
    Schmid P; Pavek P; Klein W
    Z Kardiol; 1979 Feb; 68(2):89-92. PubMed ID: 570768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy].
    Cosnay P; Fauchier JP; Lang M; Casset D; Raynaud P; Lavigne G; Itti R
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):346-55. PubMed ID: 3113357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of calcium channel blockers in hypertrophic cardiomyopathy.
    Lorell BH
    Am J Med; 1985 Feb; 78(2B):43-54. PubMed ID: 4038850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of diltiazem on left ventricular systolic and diastolic function in hypertrophic cardiomyopathy.
    Betocchi S; Piscione F; Losi M A; Pace L; Boccalatte M; Perrone-Filardi P; Cappelli-Bigazzi ; Briguori C; Manganelli F; Ciampi Q; Salvatore M; Chiariello M
    Am J Cardiol; 1996 Aug; 78(4):451-7. PubMed ID: 8752192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy in infants: clinical features and natural history.
    Maron BJ; Tajik AJ; Ruttenberg HD; Graham TP; Atwood GF; Victorica BE; Lie JT; Roberts WC
    Circulation; 1982 Jan; 65(1):7-17. PubMed ID: 6458422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hypertrophic obstructive cardiomyopathy with verapamil.
    Kaltenbach M; Hopf R; Kober G; Bussmann WD; Keller M; Petersen Y
    Br Heart J; 1979 Jul; 42(1):35-42. PubMed ID: 573129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of dual chamber pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest.
    Gadler F; Linde C; Juhlin-Dannfelt A; Ribeiro A; Rydén L
    Eur Heart J; 1997 Apr; 18(4):636-42. PubMed ID: 9129895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic effects of short term intravenous amiodarone for hypertrophic cardiomyopathy.
    Branzi A; Rapezzi C; Benenati PM; Binetti G; Piovaccari G; Bacchi M; Roncuzzi R; Zannoli R; Magnani B
    Br Heart J; 1988 Apr; 59(4):446-52. PubMed ID: 3370179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.